Guideline on quality data requirements for applications for biological veterinary medicinal products intended for limited markets

Quality data requirements for applications for biological veterinary medicinal products intended for limited markets - Scientific guideline

Concept paper for the revision of the guideline on anticoccidials used for the therapy of coccidiosis in chickens, turkeys and geese

Efficacy and target animal safety data requirements for applications for non-immunological veterinary medicinal products intended for limited markets but not eligible for authorisation under Article 23 of Regulation (EU) 2019/6 - Scientific guideline

Conversations on Cancer: Transforming patient lives by therapeutic and regulatory innovations, European Medicines Agency, Amsterdam, the Netherlands, from 1 February 2024, 15:30 (CET) to 1 February 2024, 17:00 (CET)

Conversations On Cancer presents “Living with metastatic breast cancer”, Online, European Medicines Agency, Amsterdam, the Netherlands, from 19 October 2023, 15:30 (CEST) to 19 October 2023, 17:00 (CEST)

Safety and residue data requirements for applications for non-immunological veterinary medicinal products intended for limited markets but not eligible for authorisation under Article 23 of Regulation (EU) 2019/6 - Scientific guideline

Guideline on safety and residue data requirements for applications for non-immunological veterinary medicinal products intended for limited markets but not eligible for authorisation under Article 23 of Regulation (EU) 2019/6

Cookies

Safety and efficacy data requirements for applications for immunological VMPs intended for limited markets but not eligible for authorisation under Art 23 of Reg (EU) 2019-6 - Scientific guideline